Mass General Brigham Partners with Simcere Pharmaceutical for Cancer and Autoimmune Disease Research
Top-tier US medical institution Mass General Brigham Incorporated (MGB) has signed a sponsored research agreement...
R&D
Shanghai Fosun High Technology Partners with NICE for Joint Innovation Centers
China-based conglomerate Shanghai Fosun High Technology (Group) Co., Ltd has entered into a partnership with...
Lancet Study Reveals Dalian’s Cancer Survival Rates Compared to US
A recent study published in The Lancet has conducted a comparative analysis of cancer mortality...
HuidaGene Secures US Patent for High-Efficiency Cas12Max DNA Editing System
HuidaGene Therapeutics, a China-based biotechnology company, has announced the receipt of patent protection from the...
COVID-19 Disruptions Lead to Soaring Lab Monkey Prices, Impacting US Drug Development
The COVID-19 pandemic has led to a significant reduction in the export of laboratory monkeys...
China’s CDE Releases 69th Batch of Generic Chemical Reference Preparations for Public Review
The Center for Drug Evaluation (CDE) in China has released the 69th batch of chemical...
AACR 2023 Highlights: CAR-T Therapies and Monoclonal Antibody Combinations in Cancer Research
The 2023 edition of the American Association for Cancer Research (AACR) annual meeting has concluded,...
Nona Biosciences Partners with Dr. Michael S. Diamond for Viral Disease Monoclonal Antibody Research
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), which operates in the...
Merck and XtalPi Leverage Molecular Dynamics to Enhance Small-Molecule Crystallization
German pharmaceutical giant Merck (NYSE: MRK) and China-based drug discovery solutions specialist XtalPi have published...
HuidaGene Therapeutics Enhances CRISPR-Cas12f System with Higher Editing Efficiency
HuidaGene (Shanghai) Therapeutics Co., Ltd, a China-based biotechnology company, has made significant strides in the...
Diapin Therapeutics Announces Breakthrough Preclinical Results for DT-109 in NASH Treatment
US-based biotech Diapin Therapeutics has announced groundbreaking results from the latest preclinical tests for its...
Gates Foundation and NSFC Launch Partnership to Boost Regulatory Science in Vaccine Development
The Bill & Melinda Gates Foundation (Gates Foundation) and the National Natural Science Foundation of...
AstraZeneca and HKSTP Expand Collaboration with MoU to Support Start-Ups
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) and Hong Kong Science and Technology Parks Corp....
China’s Life Expectancy on Track to Surpass 81.3 Years by 2035, Study Reveals
A recent study published in The Lancet has provided updated forecasts for life expectancy in...
Kintor Pharmaceutical Realigns Funds from COVID-19 Studies to Other Pipeline Candidates
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced a strategic change in the allocation of...
AstraZeneca Plans Tripled R&D Investment in China, Aims for 15 New Drugs by 2030
At the AstraZeneca’s (AZ, NASDAQ: AZN) R&D China Science Day, Yicai Global reported that the...
CDE Issues Guidelines on Single-Arm Clinical Trials for Antitumor Drugs
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for the Applicability of...
XtalPi and DP Technology Partner to Accelerate Pre-Clinical Drug Development with AI
Sino-US artificial intelligence (AI) firm XtalPi Inc. has entered into a partnership with Beijing-based DP...
Pasteur Institute Suspends Joint Venture with Chinese Academy of Sciences
France’s Pasteur Institute has announced its decision to suspend its joint-venture (JV) partnership with the...
Pudong New Area Grants Duty-Free Import Qualifications to Seven Companies
Seven companies have been awarded scientific and technological innovation duty-free import qualification designations by the...